Express Scripts Holding PE Ratio 2006-2018 | ESRX

Current and historical PE ratio for Express Scripts Holding (ESRX) from 2006 to 2018. The price to earnings or PE ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Express Scripts Holding (ESRX) as of March 31, 2018 is 10.26.
Sector Industry Market Cap Revenue
Medical Medical Services $0.008B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.579B 25.43
PRA Health Sciences (PRAH) United States $6.569B 31.45
Charles River Laboratories (CRL) United States $5.954B 23.14
INC Research Holdings (SYNH) United States $5.160B 22.71
HealthEquity (HQY) United States $5.109B 108.34
Premier (PINC) United States $4.942B 19.99
Teladoc (TDOC) United States $4.273B 0.00
NovoCure (NVCR) Jersey $3.406B 0.00
AMN Healthcare Services Inc (AMN) United States $2.929B 22.34
Intrexon (XON) United States $1.907B 0.00
Medpace Holdings (MEDP) United States $1.705B 27.11
BioTelemetry (BEAT) United States $1.651B 45.77
IKang Healthcare (KANG) China $1.426B 78.96
Healthways (TVTY) United States $1.384B 19.60
Natera (NTRA) United States $1.234B 0.00
China Cord Blood (CO) China $1.034B 27.65
Apollo Medical Holdings (AMEH) United States $0.907B 0.00
Surgery Partners (SGRY) United States $0.692B 0.00
Civitas Solutions (CIVI) United States $0.601B 15.33
CareDx (CDNA) United States $0.441B 0.00
OncoCyte (OCX) United States $0.122B 0.00
Interpace Diagnostics (IDXG) United States $0.029B 0.00
Cancer Genetics (CGIX) United States $0.026B 0.00
Biocept (BIOC) United States $0.014B 0.00
OpGen (OPGN) United States $0.012B 0.00
FORM Holdings (XSPA) United States $0.008B 0.00